Clinical correlation analysis revealed that elevated EPS8L2 expression is associated with advanced tumor grade, lymph node metastasis, and unfavorable patient prognosis, suggesting its potential role in CRC progression and aggressiveness. The gene discussed is EPS8L2; the disease is colorectal carcinoma.